FTL008.16 / Sound Biopharma - LARVOL DELTA

Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16 (clinicaltrials.gov) - P1 | N=68 | Recruiting | Sponsor: Sound Biopharmaceuticals Ltd. | Not yet recruiting ➔ Recruiting | Trial completion date: May 2027 ➔ Nov 2027 | Trial primary completion date: Jan 2026 ➔ Nov 2026

Enrollment open • Trial completion date • Trial primary completion date • Solid Tumor

Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16 (clinicaltrials.gov) - P1 | N=68 | Not yet recruiting | Sponsor: Sound Biopharmaceuticals Ltd.

Metastases • New P1 trial • Oncology • Solid Tumor